July 5, 2023 – Scientists Identify Viroid-Resistant Purple Cannabis Strain – SFGate reports that scientists from Massachusetts-based Medicinal Genomics observed a cannabis variety, Jamaican Lion, that appears to be partially resistant to HLVd, and it turns purple as it fights the viroid.
April 24, 2023 – Medicinal Genomics Welcomes Cannabis Investors to CannMed 23 Innovation & Investment Summit, May 15-17, Marco Island, FL – “We’re very happy to be able to add the investment component to CannMed 23,” said Brendan McKernan, Medicinal Genomics CEO. “Every new market, especially those with as much potential as this one, attracts a great deal of interest. But it’s also uncharted territory. That’s why we’re thrilled to have a leader with David’s expertise and reputation, and why we’ve had such a great response.”
February 28, 2023 – Medicinal Genomics Unveils Its Compendium of State-by-State Cannabis Microbial Testing Regulations – We at Medicinal Genomics Corporation (MGC) have cataloged the cannabis microbial testing regulations by state as the first step in an effort to shed light on the disarray of the industry’s regulatory status.
February 27, 2023 – Medicinal Genomics Debuts Immersive Workshop Format at CannMed 23 – All the Workshops will be held on Monday, May 15th to allow attendees two full days at the conference proper. As always, CannMed gathers some of the foremost medicinal plant thought leaders, scientists, physicians, and advocates from around the world who will come together to present the latest advances in medicinal plant therapeutics on the conference’s final two days.
November 3, 2022 – New York loosened weed testing rules for mold and yeast—Here’s why – The majority of states have a 10,000 CFU threshold for total yeast and mold, according to Medicinal Genomics. Maryland, Michigan, and Florida have some of the highest acceptable yeast and mold limits, while Utah (1,000), Illinois (1,000), and Iowa (10) have among the lowest.
November 2022 – Custom Highs – GMO weed is the next step to demystifying your favorite drug – Medicinal Genomics, the cannabis genetic company that organized the conference, claims it was the first to sequence the cannabis genome in 2011. While genomic breeding has been used in the agricultural industry for decades, due to restrictive legislation under prohibition, the first crude map of the weed genome was only published in the 2010s — a feat that allowed scientists to delve deeper into how exactly cannabis plants inherit their chemical profiles.
September 30, 2022 – New Research Shows that Cannabis Trichomes Trigger Positive Results on Rapid Yeast and Mold Plates – Kevin McKernan, Chief Scientific Officer and Founder of Medicinal Genomics, shares some insight behind his recently published paper related to cannabis trichomes and positive results on rapid yeast and mold plates. In a recent pre-print article by Kevin McKernan and Yvonne Helbert of Medicinal Genomics (1), they present latest findings from their laboratories demonstrating that certain trichome-rich strains can be mistaken for pathogen-rich samples.
August 10, 2022 – 5 Viruses to Watch Out for in Your Cannabis Grow – we interviewed Liam Kane, R&D Scientist at Medicinal Genomics, about each virus and its role in cannabis. Liam has designed and internally validated all of Medicinal Genomics’ cannabis virus assays, including but not limited to: the primer design, testing with various Master Mixes, and an assay optimization process.
May 26, 2022 – Mold in medical marijuana? Yes, and here’s what Connecticut is doing about it – The Department of Consumer Protection brought in Sherman Hom, director of regulatory affairs for Medicinal Genomics, on May 10 to speak with committee members and answer their questions. DCP Commissioner Michelle Seagull was also present, said department spokeswoman Kaitlyn Krasselt.
May 13, 2022 – Cannabis Healthcare for the Nation: CannMed Returns – CannMed, the premium industry meeting for cannabis science run by Medicinal Genomics (the world leader in cannabis genetics and microbial detection), returned for its first in-person event in more than two years May 3-5, bringing scientists and thought leaders from around the planet to Pasadena, California, for three days of education, exhibiting and patient-focused networking.
Apr 28, 2022 – CannMed highlights advances in ‘Mother Nature’s pharmacy’ – CannMed 2022 will bring together industry leaders, the latest innovations and research as well as the “father of cannabis research” to the Pasadena Convention Center Tuesday, May 3, to Thursday, May 5.
April 24, 2022 – Humboldt Grace Legacy Project Launches ‘Comprehensive White Paper’ – The Humboldt Grace Legacy Project (HGLP) is a collaborative working group founded by Lelehnia Dubois which seeks to defend, preserve and promote small, independent/craft farmers and breeders.
April 5, 2022 – Use of SureSelect NGS Panels for Genotype-to-Chemotype Classification in Cannabis sativa L. – The genome of Cannabis sativa L. is about 900 Mb — 63 percent AT-rich and one-to-two percent polymorphic. Due to its size and repetitive nature, targeted sequencing approaches are desirable.
March 31, 2022 – How Are Microorganisms and Mycotoxins Detected in Cannabis? – a team of scientists found culture-based techniques don’t offer the same accuracy, precision and repeatability as genetic sequencing technology. This not only risks the integrity of the medical cannabis industry but puts consumers at risk.
March 3, 2022 – Challenges with Microbial Contaminant Testing for Cannabis Laboratories – As the legal cannabis industry continues to grow, issues remain for laboratories to accurately perform microbial contaminant testing
February 24, 2022 -CannMed 2022: Medical Practicum Organizers Share Their Insight, Part II: Dr. Kevin Spelman – In this interview series, we speak to each of the organizers to learn more about them and what attendees can expect from the practicum. Here in Part II, Dr. Kevin Spelman shares his insights.
Feb 7, 2022 – Should Connecticut change mold and yeast levels in cannabis? – Sherman Hom, director of regulatory affairs for Medicinal Genomics, submitted two letters suggesting changes to testing procedures.
February 3rd, 2022 – Cannabis Science and Technology® and LCGC® to Host Two-Day Live Virtual Symposium: “Grow Your Skills in the Budding Cannabis Industry” – “Workshop Topic: Microbial Testing” presented by Heather Ebling, Applications and Support Manager, Medicinal Genomics Corporation
January 22, 2022 – Why Cannabis Needs Its Own Set of Safety Standards – An overview of the changes needed to increase standards and regulations in the cannabis industry and why they are so important.
November 5, 2021 – Hop Latent Viroid. Why the Smallest Cannabis Pathogen is the Biggest Problem – HLVd is most commonly spread via mechanical infection from equipment. Cultivators who prune an infected plant, and then turn around and use the same shears/scissors to work on its neighbor have just spread the infection.
October 25th, 2021 – Medicinal Genomics Publishes Genome of Psilocybe Cubensis – Scientists at Medicinal Genomics, a specialist cannabis testing and genetics screening firm, have published a peer-reviewed, highly-contiguous reference genome for the psychedelic mushroom species Psilocybe cubensis.
September 1, 2021 -The Major Magic Mushroom Species You Should Know About – Earlier this year, Medicinal Genomics published a highly contiguous reference genome for P. cubensis, which the team hopes will inform more research into the genes of interest and pathways responsible for producing psilocybin.
May 17th, 2021 – Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass Dartmouth – The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.
July 30th, 2021 – Medical Cannabis Insights, Part II: How Cannabis Helps Opioid Addiction and A Discussion on Interactions with Other Medications – In this roundtable interview series, we speak to each of the organizers to learn more about them and what attends can expect from the practicum. Here in part II, they discuss how cannabis can be used stop opioid addiction and possible ways cannabis might interact with other prescription medications.
June 28th, 2021 – Medical Cannabis Insights, Part I: CannMed Medical Practicum Organizers Discuss Clinical Applications and Dosing – In this roundtable interview series, we speak to each of the organizers to learn more about them and what attendees can expect from the practicum. Here in part I, they share some of the clinical applications for medical cannabis and dosing information.
May 4th, 2021 – World Changing Ideas Awards 2021: Established Excellence (5-14 Years In Business) Finalists and Honorable Mentions – Companies that have achieved incredible impact and have been in business between 5 and 14 years.
May 4th, 2021 – 2021 Cannabis Labs Virtual Conference: May Program – qPCR vs Plating: Which is Right for Your Lab? Heather Ebling compares the differences between molecular and culture based microbial testing, explains the advantages and disadvantages of each method and guides attendees through how to evaluate the two different microbial testing methods.
June 14th 2020 – Cannabis plant may harbor SARS-CoV-2 for at least a week Researchers at the Medicinal Genomics Corporation have warned that cannabis flowers exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may harbor the virus for at least seven days.
April 6, 2020 – Cannabis and Coronavirus: Help Keeps Coming from Industry Businesses – Medicinal Genomics Corp. (MGC) has pledged proceeds from ticket sales for its CannMed 2020 tradeshow, will be donated to pandemic relief.
March 3, 2020 – Pharmaceutical company claims to have developed a cannabis treatment for coronavirus symptoms – Kevin McKernan, founder of Massachusetts-based life sciences company, Medicinal Genomics, tweeted, “Bummer. There is actually some exciting preliminary work on cannabinoids and viruses that are now getting sold before it’s (…) understood.”
January 29, 2020 – Arbor Biosciences, Biosearch Technologies Ink Global Distribution Deal for Ag-Bio NGS Panels – Over the last year, the firm has formed partnerships with Curio Genomics on bioinformatics for a wheat exome panel and with Medicinal Genomics for a cannabis genotyping panel.
December 11, 2019 – One man’s crusade to open-source cannabis DNA – The best way to circumvent future attempts to patent all or part of the plant’s DNA would be to create a genome map for a specific strain and put it in the public domain.
October 21, 2019 -3 Essential Components of Microbial Safety Testing – Microbial contamination on cannabis products represents one of the most significant threats to cannabis consumers, particularly immunocompromised patients who are at risk of developing harmful and potentially fatal infections.
September 11, 2019 – Collaboration to Advance Marker Discovery and Genotyping in Cannabis – MGC has identified the genetic variations that cause a plant to produce the important cannabinoids of THC, CBD, and their combinations, referred to as chemotypes (I-IV). This information provides a genetic fingerprint for different types and cultivars, and is a key to selective breeding of cannabis.
August 26, 2019 – How Phylos Bioscience sent shockwaves through the cannabis industry with ‘Big Ag’ disclosure – Cannabis growers and breeders are worried that genetics patents and data could be controlled by large corporate entities, which would limit genetic diversity and force smaller cannabis producers to pay more for seeds and clones.
May 30, 2019 – Game Of Genomes: The Battle For The King Of Cannabis Strains Is Just Heating Up A cannabis Ancestry.com
May 22, 2019 -VegaWallet and Covault Partner to Bring Dash Payments to Cannabis Dispensaries Then research firm Medicinal Genomics is using Dash to protect everyday cannabis growers from big pharma corporations attempting to patent cannabis plant genomes.
May 21, 2019 – Dash Platform, DAPI, and Drive Value Propositions Further Enhances Dash Network Then there are companies like Medicinal Genomics currently hashing genome data to the Dash Network to prove cannabis research and genetic makeup
May 16, 2019 -Podcast: One Company’s Quest to be the 23andMe of Cannabis So I went to work with a company called medicinal genomics, and my job I was collect samples of different plants,
May 8, 2019 – Medicinal Genomics Solutions in Israeli Cannabis Market Medicinal Genomics, a genomics and blockchain technology company engaged in improving the yield, safety and transparency of cannabis, signed an agreement with Eldan to launch its services in the Israeli cannabis market.
April 18, 2019 – Dr. Jon Cachat: Training Future Cannabis Lab Techs Medicinal Genomics. These companies make genetic based, PCR based, microbial tests, so in our tests that we’re testing for mold.
March 6, 2019 – Hamilton Robotics Joins with Medicinal Genomics to Provide Reliable Automated Cannabis Testing Solutions Robust, High-Throughput Solutions Help Cannabis Testing Facilities to Support Product Quality and Consumer Safety while Reducing Turnaround Times
February 18, 2019 – Dash Leads Cryptocurrency Growth on Uphold Medicinal Genomics to improve cannabis research and data storage
February 11, 2019 – Medicinal Genomics Releases Industry’s First Comprehensive Cannabis Reference Genome Medicinal Genomics Corporation (MGC), a pioneer in using genomics to improve the transparency, safety and yield of cannabis has today announced the industry’s most comprehensive cannabis reference genome
February 9, 2019 – SEQUENCING THE CANNABIS GENOME The Massachusetts-based company Medicinal Genomics had sequenced the entire genome of Cannabis sativa L. How will this impact scientific research and public health?
January 22, 2019 – Medicinal Genomics Releases Industry’s First Comprehensive Cannabis Reference Genome Genetic milestone in mapping the cannabis genome to be made public to accelerate research and commercialization
January 7, 2019 – Medicinal Genomics and Eiken Chemical partnership expected to drive higher yield, productivity Medicinal Genomics Corp. (MGC) hopes to accelerate detection of cannabis genes, genotypes, pests and pathogens through a new licensing agreement with Eiken Chemical Co., Ltd. that covers use of a dozen patents related to the latter company’s technology.
November 27, 2018 – The Blockchain Could Save Legalized Weed. (Stop Rolling Your Eyes.) Enter Medicinal Genomics, one company offering a way for cannabis growers to protect themselves in anticipation of future patent litigation.
November 20, 2018 – Optimized Cannabis Microbial Testing: Combined Use of Medicinal Genomics Extraction Methods With the AriaMx qPCR Instrument
November 1, 2018 – What is Patent 6,630,507? Why The Feds Hold a Patent On CBD Treatments. Bacca explained a Massachusetts-based company Medicinal Genomics is working to sequence a popular landbased strain Jamaican Lion
October 31, 2018 – Challenges in Cannabis Genome Sequencing for Genetic Tracking and Traceability Kevin McKernan, chief scientific officer of Medicinal Genomics, has been working feverishly to bridge the information gap between the cannabis genome and other widely studied plant genomes.
October 30, 2018 – CannMed 2018 Put the Spotlight on Developments in Cannabis Research The 3rd annual CannMed conference took place last week at The UCLA Luskin Conference Center at The University of California in Los Angeles (UCLA).
October 18, 2018 – Medicinal Genomics Uses Dash To Disrupt Academic Peer Review Process and Cannabis Industry – Medicinal Genomics, the cannabis genome mapping company funded by the Dash network, has recently released a pre-print of their paper discussing their findings of mapping a larger part of the cannabis genome ever done to date.
October 17, 2018 – What legal weed in Canada means for science – A complete cannabis genome would make it easier to identify informative DNA markers.
October 11, 2018 – California Employment Development Department and CannMed 2018 host inaugural Cannabis Career Fair – The State of California’s Employment Development Department (EDD) will partner with Medicinal Genomics’ CannMed Medicinal Cannabis conference to host a Cannabis Career Fair
September 13, 2018 – Vitality Biopharma Scientific Co-Founder to Present Recent Data at CannMed Medical Conference in Los Angeles – Dr. Brandon Zipp will give a scientific presentation about VBX-100, Vitality’s proprietary THC prodrug, at CannMed 2018 in Los Angeles, CA.
August 2nd, 2018 – Dash and Medicinal Genomics Beats DNA Sequencing Record of Human Genome Project – Dash’s partnership with Medicinal Genomics (MGC) continues to reap rewards by breaking DNA genome sequencing records set by the Human Genome Project in 2001.
July 24th, 2018 – CannMed 2018 Conference Features the Greatest Minds in Cannabis Research, Medicine, and Cultivation – Among the “great minds” gathering at CannMed 2018 is the “Father of Cannabinoid Research,” Dr. Raphael Mechoulam
July 24th, 2018 – CannMed 2018 Conference Features the Greatest Minds in Cannabis Research, Medicine, and Cultivation – CannMed 2018 is a gathering of the greatest minds in medical cannabis, where they will further the convergence of medical cannabis research, treatment, and product development.
July 24th, 2018 – Woburn Company Wants To Make Marijuana Safer – Woburn-based Medicinal Genomics is the only company to complete an application to conduct safety tests on marijuana.
July 23rd, 2018 – This Woburn company is ready to test pot – Woburn-based Medicinal Genomics claims its tests, which cost about $5 each per sample, have a specificity of 96.3 percent for bacterial contaminants and 99.97 percent for fungal ones.
May 27, 2018 – Scientists, Funded By Crypto, Using Blockchain to Stop Monsanto from Taking Over Cannabis Industry – Medical Genomics, the group behind the project, is publishing all of their results at Kannapedia.com using their StrainSEEK Identification and Registration service.
May 21, 2018 – Medicinal Genomics youPCR Platform: Helping Growers Screen Plants for Pathogens Before They Show Visual Signs – Medicinal Genomics expanded its youPCR™ Plant Screening Platform to include three new detection assays for common cannabis plant pathogens: botrytis, fusarium, and russet mites.
April 20, 2018 – Benefits of Cannabis Genetics for Producing Weed– Medicinal Genomics’ StrainSEEK platform maps and sequences the DNA of different cannabis strains.
November 6, 2017 – Meet Brendan and Kevin McKernan of Medicinal Genomics in Woburn – We started by making microbial testing kits to test for the presence of harmful microbes. We also started working with breeders to improve breeding programs using genetics.
September 21, 2017 – Interview With Kevin Mckernan, Chief Science Officer Behind StrainSEEK – While he may not be a household name, Kevin Mckernan’s work sequencing the genomes of cannabis strains is incredibly fascinating.
July 24, 2017 – Courtagen Life Sciences Shifts Focus to its Medicinal Cannabis Genetics and Testing Business – MGC is a commercial stage company focused on helping growers and scientists to identify desirable genetic traits of interest and to detect harmful microbes
July 18, 2017 – CannMed 2017 Premier Medical Marijuana Conference to Feature Global Industry Leaders, Physicians, Scientists, Politicians, Athletes, Attorneys, and Media Gathering to Discuss Medicine, Legalization, Opioids vs. Cannabis, Pain Management, and More – This year’s CannMed event is drawing international attention as cannabis research and legalization continues to grow exponentially.
January 31, 2017 – Medicinal Genomics Hosts CannMed 2017 Conference in Boston with Hawaiian Connection – The conference will also provide an opportunity for local physicians and businesses participating in the medical cannabis program to advance their education and network with providers from other states.
January 26, 2017 – Medicinal Genomics, Courtagen Announce NIDA Grant for Testing Medical Cannabis – Medicinal Genomics and Courtagen Life Sciences has announced that the National Institute on Drug Abuse (NIDA) has awarded the company an SBIR Phase I grant to develop a novel test to detect toxins resulting from microbiological contamination of medical cannabis.
January 25th, 2017 – Medical Cannabis Toxin Test Funded by National Institute on Drug Abuse – Test development will center around detecting presence of toxic products left behind by rogue molds and bacteria on medical cannabis
December 10, 2016 This Company Uses Bitcoin Blockchain For Medical Marijuana DNA Sequencing – molecular information company called Medicinal Genomics (MCG) has partnered with 12 cannabis processors and cultivators to develop genomics-based safety and quality standards
December 5, 2016 – Medicinal Genomics Seeks to Put Cannabis on the Blockchain – Motherboard reports that Medicinal Genomics is creating a registered list of all cannabis genomes to be stored on the bitcoin blockchain.
December 1, 2016 – Medicinal Genomics and Courtagen Life Sciences Announce CannMed 2017, the Personalized Cannabinoid Medicine Conference, April 9-11, 2017 – The conference will focus on the intersection of clinical application, medical research, cannabis-based therapeutics, cannabis safety and production.
November 15, 2016 – Potchain 1.0: Why the Legal Weed Industry Is Embracing Blockchain – Boston-based Medicinal Genomics uses a service called StrainSEEK to map and sequence the DNA of different cannabis strains, then register that information and store it on the Bitcoin blockchain.
March 11, 2016 – Why Marijuana Growers Are Racing to Register Their Strains on the Bitcoin Blockchain – Medicinal Genomics’ goal is to standardize strain nomenclature so that customers can know what they’re getting when they buy medical marijuana, while also defending the intellectual property rights of those who breed new cannabis strains.
November 2, 2016 – Bitcoin Blockchain Attracts Weed Growers; Register Strain Origins – As a solution, Medicinal Genomics has developed a Bitcoin Blockchain-based weed depository with which weed growers can register their cannabis strains with genomic data while users, brokers and consumers can verify the strain by referring to the public irrefutable ledger of Bitcoin.
October 29, 2016 – Weed Growers Are Racing to Register Their Strains on the Bitcoin Blockchain – Yet what sets this company apart is that their labs are also offering customers the ability to sequence the genome of their cannabis plants.
October 17, 2016 – How Medicinal Genomics Is Using DNA Sequencing to Improve the Cannabis Industry – One of the ways in which DNA identification helps is that growers and consumers can more easily and accurately navigate the myriad strains and ensure that they’re properly named and consistent across regions.
October 6, 2016 – Woburn company applies DNA sequencing to budding marijuana industry – “We set out to ask, what questions can we answer with DNA?” said Kevin McKernan, chief scientific officer for Medicinal Genomics
April 20, 2016 – Medicinal Genomics Revolutionizes Cannabis Industry with Introduction of Strain ID & Certification Service – Consumers and clinicians are, for the first time, able to identify the exact strain and key characteristics of the cannabis and hemp they are purchasing, enabling confidence in the quality and reliability of the product.
April 6, 2016 – CannMed 2016 Conference to Be Live Streamed Including the Keynote Speech by Noted Israeli Marijuana Research Pioneer Dr. Raphael Mechoulam – Speakers include Dr. Raphael Mechoulam, cannabis research pioneer and the “Father of Marijuana Research,” and Kyle Turley, former NFL All-Pro player and founder of the Gridiron Cannabis Coalition.
January 5, 2016 – KEVIN MCKERNAN: SEQUENCING THE CANNABIS GENOME – Kevin McKernan on sequencing the cannabis genome and its implications for the cannabis industry and “personalized medicine.”
January 13, 2016 – Medicinal Genomics Corporation and Courtagen Life Sciences Announce CannMed 2016, the Personalized Cannabinoid Medicine Conference, April 10-11, 2016 – The conference will be the first to focus on the intersection of clinical application, medical research, and cannabis based therapeutics related to neurological disorders, such as epilepsy, developmental delay, chronic and neuropathic pain, Alzheimer’s, Parkinson’s, traumatic brain injury, as well as other disease areas.
December 14, 2015 – Genome-wide analyses reveal clustering in Cannabis cultivars: the ancient domestication trilogy of a panacea – I used an open access data set (Medicinal Genomics) consisting of nearly 200’000 genome-wide single nucleotide polymorphisms (SNPs) typed in 28 cannabis accessions to shed light on the plant’s underlying genetic structure.
March 26, 2015 – THE DNA OF THC – Medicinal Genomics, became the first outfit to map the genome of cannabis sativa and indica.
November 5, 2013 – The Story of the Human Genome Project is a Libertarian Greek Tragedy – The genome sequence has initiated a new economic frontier and it is as impactful as the potential for alternative or competitive crypto currencies like Bitcoin.
January 25th, 2012 – Family Affair: Courtagen Applies Management DNA to Genomics Startup – The three brothers previously founded DNA sequencing company Agencourt Bioscience and its spinoff, Agencourt Personal Genomics.
January 18, 2012 – Courtagen Life Sciences Acquires Medicinal Genomics – Medicinal Genomics made headlines around the world last August when it announced that it had sequenced the entire genome of Cannabis sativa and Cannabis indica, assembling the largest known gene collection of this therapeutic plant.
January 18, 2012 – McKernan Brothers Reunite As Courtagen Buys Medicinal Genomics – Courtagen Life Sciences Inc., a venture-backed provider of technology and services to enable “precision medicine,” has acquired privately held Medicinal Genomics Corp. to secure resources that will enable it to better elucidate the therapeutic potentials of cannabis.
September 27, 2011 – Kevin McKernan Leaves Life Technologies on a High – Kevin McKernan’s new joint—a start-up company called Medicinal Genomics—is gaining attention by sequencing the cannabis genome, which could have important implications for cancer treatment.
August 23, 2011 – Sequencing The Marijuana Genome To Cure Disease, Get You Less High – Medicinal Genomics has just finished sequencing the cannabis genome. Not to make some truly righteous bud, but to find the parts of the plant that are medicinally valuable and make them into drugs that don’t also get people stoned.
August 23, 2011 – Buzz Kill: Marijuana Genome Sequenced For Health, Not Highs – Last week, a company called Medicinal Genomics announced that it sequenced the genomes for cannabis sativa and cannabis indica–two of the three species of marijuana (the third is cannabis ruderalis).
August 18, 2011 – Genome of Marijuana Sequenced and Published – A Netherlands-based company called Medicinal Genomics has just announced the successful genetic sequencing of Cannabis sativa.
August 18, 2011 – Medicinal Genomics Sequences the Cannabis Genome Using Roche’s GS FLX+ System – The genome assemblies, comprising over 131 billion bases of sequence, are the largest known gene collection of the Cannabis genomes and will be made publicly available to the scientific community this fall.
August 18, 2011 – For The Love Of Bud, Marijuana Genome Sequenced – According to McKernan, he was inspired to sequence the weed genome due to the potential medical uses of cannabinoids.
August 18, 2011 – Medicinal Genomics Sequences the Cannabis Genome to Assemble the Largest Known Gene Collection of this Therapeutic Plant – To date, Medicinal Genomics has privately sequenced over 131 billion bases of sequence, which represents a 65,000 fold increase in what has been publicly shared about the Cannabis genome.
©2024 MEDICINAL GENOMICS CORPS
Copyright all right reserved.
Signup to receive email updates on blog posts, podcasts, webinars, new products, and more!
Join us at the CannMed 24 Innovation and Investment Summit, an exclusive experience of discovery, development, and networking with innovators from around the world.
